Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Basik M"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-18 z 18
    Tytuł:
    A Non-Hazardous Deparaffinization Protocol Enables Quantitative Proteomics of Core Needle Biopsy-Sized Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Specimens.
    Autorzy:
    Mitsa G; Division of Experimental Medicine, McGill University, Montreal, QC H4A 3J1, Canada.; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
    Guo Q; Division of Experimental Medicine, McGill University, Montreal, QC H4A 3J1, Canada.; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A 3T2, Canada.
    Goncalves C; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A 3T2, Canada.
    Preston SEJ; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A 3T2, Canada.
    Lacasse V; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.; Research Pathology Core Facility, Department of Pathology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
    Aguilar-Mahecha A; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A 3T2, Canada.
    Benlimame N; Research Pathology Core Facility, Department of Pathology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
    Basik M; Division of Experimental Medicine, McGill University, Montreal, QC H4A 3J1, Canada.; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A 3T2, Canada.
    Spatz A; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A 3T2, Canada.; Research Pathology Core Facility, Department of Pathology, Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
    Batist G; Division of Experimental Medicine, McGill University, Montreal, QC H4A 3J1, Canada.; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A 3T2, Canada.; Exactis Innovation, 5450 Cote-des-Neiges, Suite 522, Montreal, QC H3T 1Y6, Canada.
    Miller WH Jr; Division of Experimental Medicine, McGill University, Montreal, QC H4A 3J1, Canada.; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A 3T2, Canada.; Rossy Cancer Network, McGill University, Montreal, QC H3H 1E8, Canada.
    Del Rincon SV; Division of Experimental Medicine, McGill University, Montreal, QC H4A 3J1, Canada.; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A 3T2, Canada.
    Zahedi RP; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
    Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A 3T2, Canada.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2022 Apr 18; Vol. 23 (8). Date of Electronic Publication: 2022 Apr 18.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Paraffin*
    Proteomics*/methods
    Biopsy, Large-Core Needle ; Formaldehyde ; Humans ; Paraffin Embedding ; Proteome/metabolism ; Tissue Fixation
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Early, On-Treatment Levels and Dynamic Changes of Genomic Instability in Circulating Tumor DNA Predict Response to Treatment and Outcome in Metastatic Breast Cancer Patients.
    Autorzy:
    Aguilar-Mahecha A; Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
    Lafleur J; Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
    Brousse S; Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
    Savichtcheva O; Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
    Holden KA; Laboratory Corporation of America, Burlington, NC 27216-2240, USA.
    Faulkner N; Laboratory Corporation of America, Burlington, NC 27216-2240, USA.
    McLennan G; Laboratory Corporation of America, Burlington, NC 27216-2240, USA.
    Jensen TJ; Laboratory Corporation of America, Burlington, NC 27216-2240, USA.
    Basik M; Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2021 Mar 16; Vol. 13 (6). Date of Electronic Publication: 2021 Mar 16.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer.
    Autorzy:
    Cavallone L; Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.
    Aguilar-Mahecha A; Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.
    Lafleur J; Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.
    Brousse S; Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.
    Aldamry M; Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.
    Roseshter T; Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.
    Lan C; Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.
    Alirezaie N; Department of Human Genetics, McGill University, Montreal, QC, Canada.
    Bareke E; Department of Human Genetics, McGill University, Montreal, QC, Canada.
    Majewski J; Department of Human Genetics, McGill University, Montreal, QC, Canada.
    Ferrario C; Department of Oncology, Jewish General Hospital, Montreal, QC, Canada.
    Hassan S; Division of Surgical Oncology, Department of Surgery, Centre Hospitalier de L'Université de Montréal (CHUM), Montreal, QC, Canada.
    Discepola F; Department of Radiology, Jewish General Hospital, Montreal, QC, Canada.
    Seguin C; Department of Radiology, Jewish General Hospital, Montreal, QC, Canada.
    Mihalcioiu C; Department of Oncology, McGill University, Montreal, QC, Canada.
    Marcus EA; Cook County Hospital, Chicago, IL, USA.
    Robidoux A; Division of Surgical Oncology, Department of Surgery, Centre Hospitalier de L'Université de Montréal (CHUM), Montreal, QC, Canada.
    Roy JA; Hôpital du Sacré-Cœur de Montréal, Montreal, QC, Canada.
    Pelmus M; Department of Pathology, Jewish General Hospital, Montreal, QC, Canada.
    Basik M; Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada. mark.basik@mcgill.ca.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Sep 07; Vol. 10 (1), pp. 14704. Date of Electronic Publication: 2020 Sep 07.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Circulating Tumor DNA/*genetics
    Triple Negative Breast Neoplasms/*genetics
    Chemotherapy, Adjuvant ; Circulating Tumor DNA/blood ; Female ; Gene Frequency ; Genes, p53 ; Humans ; Middle Aged ; Mutation Rate ; Neoadjuvant Therapy ; Prognosis ; Triple Negative Breast Neoplasms/blood ; Triple Negative Breast Neoplasms/diagnosis ; Triple Negative Breast Neoplasms/drug therapy
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Breast cancer mammospheres secrete Adrenomedullin to induce lipolysis and browning of adjacent adipocytes.
    Autorzy:
    Paré M; Université Côte d'Azur, CNRS, INSERM, iBV, Nice, France.
    Darini CY; Segal Cancer Center, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montréal, Québec, Canada.
    Yao X; Université Côte d'Azur, CNRS, INSERM, iBV, Nice, France.
    Chignon-Sicard B; Université Côte d'Azur, Pasteur 2 Hospital, Department of Plastic and Reconstructive Surgery, Nice, France.
    Rekima S; Université Côte d'Azur, CNRS, INSERM, iBV, Nice, France.
    Lachambre S; Université Côte d'Azur, CNRS, INSERM, iBV, Nice, France.
    Virolle V; Université Côte d'Azur, CNRS, INSERM, iBV, Nice, France.
    Aguilar-Mahecha A; Segal Cancer Center, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montréal, Québec, Canada.
    Basik M; Segal Cancer Center, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.
    Dani C; Université Côte d'Azur, CNRS, INSERM, iBV, Nice, France.
    Ladoux A; Université Côte d'Azur, CNRS, INSERM, iBV, Nice, France. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2020 Aug 20; Vol. 20 (1), pp. 784. Date of Electronic Publication: 2020 Aug 20.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Paracrine Communication*
    Adipocytes/*pathology
    Adrenomedullin/*metabolism
    Breast Neoplasms/*pathology
    Spheroids, Cellular/*metabolism
    Adipocytes/cytology ; Breast/cytology ; Breast/pathology ; Cell Hypoxia ; Coculture Techniques ; Female ; Humans ; Lipid Droplets/metabolism ; Lipolysis ; MCF-7 Cells ; Tumor Microenvironment ; Uncoupling Protein 1/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors.
    Autorzy:
    Savage P; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.; Department of Medicine, McGill University, Montréal, QC, H4A 3J1, Canada.
    Pacis A; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.; Canadian Centre for Computational Genomics, McGill University and Genome Quebec Innovation Centre, Montréal, QC, H3A 0G1, Canada.
    Kuasne H; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
    Liu L; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
    Lai D; Department of Molecular Oncology, British Columbia Cancer Research Centre, University of British Columbia, Vancouver, BC, V5Z 1L3, Canada.
    Wan A; Department of Molecular Oncology, British Columbia Cancer Research Centre, University of British Columbia, Vancouver, BC, V5Z 1L3, Canada.
    Dankner M; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.; Department of Medicine, McGill University, Montréal, QC, H4A 3J1, Canada.
    Martinez C; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.; Department of Pathology, McGill University, Montréal, QC, H4A 3J1, Canada.
    Muñoz-Ramos V; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
    Pilon V; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
    Monast A; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
    Zhao H; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
    Souleimanova M; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
    Annis MG; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
    Aguilar-Mahecha A; Lady Davis Research Institute, Jewish General Hospital, Montréal, QC, H3T 1E2, Canada.
    Lafleur J; Lady Davis Research Institute, Jewish General Hospital, Montréal, QC, H3T 1E2, Canada.
    Bertos NR; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.
    Asselah J; Department of Oncology, McGill University, Montréal, QC, H4A 3T2, Canada.
    Bouganim N; Department of Oncology, McGill University, Montréal, QC, H4A 3T2, Canada.
    Petrecca K; Department of Neurology and Neurosurgery, McGill University, Montréal, QC, H3A 2B4, Canada.
    Siegel PM; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada.; Department of Medicine, McGill University, Montréal, QC, H4A 3J1, Canada.
    Omeroglu A; Department of Pathology, McGill University, Montréal, QC, H4A 3J1, Canada.
    Shah SP; Department of Molecular Oncology, British Columbia Cancer Research Centre, University of British Columbia, Vancouver, BC, V5Z 1L3, Canada.; Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
    Aparicio S; Department of Molecular Oncology, British Columbia Cancer Research Centre, University of British Columbia, Vancouver, BC, V5Z 1L3, Canada.
    Basik M; Lady Davis Research Institute, Jewish General Hospital, Montréal, QC, H3T 1E2, Canada.; Department of Surgery, Jewish General Hospital, Montréal, QC, H3T 1E2, Canada.
    Meterissian S; Department of Surgery, McGill University Health Centre, Montréal, QC, H4A 3J1, Canada.
    Park M; Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montréal, QC, H3A 1A3, Canada. .; Department of Medicine, McGill University, Montréal, QC, H4A 3J1, Canada. .; Department of Pathology, McGill University, Montréal, QC, H4A 3J1, Canada. .; Department of Biochemistry, McGill University, Montréal, QC, H3A 1A3, Canada. .
    Pokaż więcej
    Źródło:
    Communications biology [Commun Biol] 2020 Jun 16; Vol. 3 (1), pp. 310. Date of Electronic Publication: 2020 Jun 16.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast Neoplasms/*drug therapy
    Breast Neoplasms/*genetics
    Xenograft Model Antitumor Assays/*methods
    Animals ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Drug Resistance, Neoplasm ; Drug Screening Assays, Antitumor/methods ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Mice, Inbred NOD ; Mutation ; Precision Medicine ; Prognosis ; Proof of Concept Study ; Protein Array Analysis/methods ; Whole Genome Sequencing
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer.
    Autorzy:
    Hosein AN; Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada. .; Department of Pharmacology & Therapeutics, McGill University, Montreal, Canada. .
    Livingstone J; McGill Centre for Bioinformatics, Montreal, Canada. .
    Buchanan M; Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada. .
    Reid JF; Fondazione IFOM Istituto FIRC di Oncologia Molecolare, Milan, Italy. .
    Hallett M; McGill Centre for Bioinformatics, Montreal, Canada. .
    Basik M; Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada. mark.basik@mcgill.ca.; Department of Oncology, McGill University, Montreal, Canada. mark.basik@mcgill.ca.; Department of Surgery, McGill University, Montreal, Canada. mark.basik@mcgill.ca.; Department of Oncology, Lady Davis Institute, 3755 Cote Ste Catherine, Montreal, QC, H3T1E2, Canada. mark.basik@mcgill.ca.
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2015 Mar 15; Vol. 15, pp. 130. Date of Electronic Publication: 2015 Mar 15.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast Neoplasms/*metabolism
    Fibroblasts/*metabolism
    Gene Expression Profiling/*methods
    Interferons/*metabolism
    Breast Neoplasms/genetics ; Coculture Techniques/methods ; Cohort Studies ; Female ; Fibroblasts/drug effects ; Humans ; Interferons/pharmacology ; MCF-7 Cells
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Chromosome-breakage genomic instability and chromothripsis in breast cancer.
    Autorzy:
    Przybytkowski E; Department of Oncology, Lady Davis Institute for Medical Research, McGill University, 3755 Cote Ste-Catherine Road, Montreal, Quebec H3T-1E2, Canada. .
    Lenkiewicz E
    Barrett MT
    Klein K
    Nabavi S
    Greenwood CM
    Basik M
    Pokaż więcej
    Źródło:
    BMC genomics [BMC Genomics] 2014 Jul 09; Vol. 15, pp. 579. Date of Electronic Publication: 2014 Jul 09.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Chromosome Breakage*
    Breast Neoplasms/*genetics
    Genomic Instability/*genetics
    Breast Neoplasms/pathology ; Chromosomes, Human/genetics ; Comparative Genomic Hybridization ; Genetic Predisposition to Disease/genetics ; Genomics ; Humans ; Middle Aged ; Neoplasm Grading
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    RSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trial.
    Autorzy:
    Keilty D; Department of Oncology and Surgery, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
    Buchanan M; Department of Oncology and Surgery, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
    Ntapolias K; Department of Pathology, Jewish General Hospital, Montreal, Quebec, Canada.
    Aleynikova O; Department of Pathology, Jewish General Hospital, Montreal, Quebec, Canada.
    Tu D; NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Ontario, Canada.
    Li X; NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Ontario, Canada.
    Shepherd L; NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Ontario, Canada.
    Bramwell V; Department of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
    Basik M; Department of Oncology and Surgery, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2013 Dec 19; Vol. 8 (12), pp. e81740. Date of Electronic Publication: 2013 Dec 19 (Print Publication: 2013).
    Typ publikacji:
    Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antineoplastic Agents, Hormonal/*therapeutic use
    Breast Neoplasms/*drug therapy
    Breast Neoplasms/*genetics
    Cyclin D1/*genetics
    Nuclear Proteins/*genetics
    Tamoxifen/*therapeutic use
    Trans-Activators/*genetics
    Humans ; In Situ Hybridization, Fluorescence ; Premenopause ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Monoallelic chromatin conformation flanking long-range silenced domains in cancer-derived and normal cells.
    Autorzy:
    Di Paola D; Goodman Cancer Centre, McGill University, Montreal, Quebec, Canada.
    Raelson J
    Rampakakis E
    Basik M
    Zannis-Hadjopoulos M
    Bradley WE
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2013 May 16; Vol. 8 (5), pp. e63190. Date of Electronic Publication: 2013 May 16 (Print Publication: 2013).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Chromatin/*genetics
    Alleles ; Cell Line ; Cell Line, Tumor ; Chromatin Immunoprecipitation ; DNA Methylation/genetics ; Genotype ; Histones/metabolism ; Humans ; Polymorphism, Single Nucleotide/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer.
    Autorzy:
    Mamo A; Department of Oncology, Lady Davis Institute, Sir Mortimer B Davis Jewish General Hospital, McGill University, Montreal, Québec, Canada.
    Cavallone L
    Tuzmen S
    Chabot C
    Ferrario C
    Hassan S
    Edgren H
    Kallioniemi O
    Aleynikova O
    Przybytkowski E
    Malcolm K
    Mousses S
    Tonin PN
    Basik M
    Pokaż więcej
    Źródło:
    Oncogene [Oncogene] 2012 Apr 19; Vol. 31 (16), pp. 2090-100. Date of Electronic Publication: 2011 Sep 05.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genes, Tumor Suppressor*
    Breast Neoplasms/*genetics
    Nuclear Proteins/*genetics
    Transcription Factors/*genetics
    Cell Line, Tumor ; Chromosomes, Human, Pair 1 ; Codon, Nonsense ; DNA Copy Number Variations ; DNA-Binding Proteins ; Female ; Humans ; RNA/metabolism ; Transfection
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokines.
    Autorzy:
    Aguilar-Mahecha A; Department of Oncology, Lady Davis Institute, McGill University, Montreal, Quebec, Canada.
    Kuzyk MA
    Domanski D
    Borchers CH
    Basik M
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2012; Vol. 7 (6), pp. e38290. Date of Electronic Publication: 2012 Jun 06.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Biomarkers/*blood
    Blood Proteins/*analysis
    Blood Specimen Collection/*methods
    Cytokines/*blood
    Mass Spectrometry/*methods
    Proteomics/*methods
    Adult ; Blood Specimen Collection/instrumentation ; Female ; Humans ; Linear Models ; Male ; Middle Aged
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
    Autorzy:
    Ha KC; Department of Human Genetics, McGill University, Montreal, Quebec, H3A 1B1, Canada.
    Lalonde E
    Li L
    Cavallone L
    Natrajan R
    Lambros MB
    Mitsopoulos C
    Hakas J
    Kozarewa I
    Fenwick K
    Lord CJ
    Ashworth A
    Vincent-Salomon A
    Basik M
    Reis-Filho JS
    Majewski J
    Foulkes WD
    Pokaż więcej
    Źródło:
    BMC medical genomics [BMC Med Genomics] 2011 Oct 27; Vol. 4, pp. 75. Date of Electronic Publication: 2011 Oct 27.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Mutation*
    BRCA1 Protein/*genetics
    Breast Neoplasms/*pathology
    Gene Expression Profiling/*methods
    Gene Fusion/*genetics
    High-Throughput Nucleotide Sequencing/*methods
    Sequence Analysis, RNA/*methods
    Base Sequence ; Breast Neoplasms/genetics ; Cell Line, Tumor ; Chromosome Breakpoints ; DNA Copy Number Variations/genetics ; Feasibility Studies ; Female ; Humans ; Molecular Sequence Data ; RNA, Messenger/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes.
    Autorzy:
    Tabariès S; Goodman Cancer Research Centre, McGill University, Montréal, Québec, Canada.
    Dong Z
    Annis MG
    Omeroglu A
    Pepin F
    Ouellet V
    Russo C
    Hassanain M
    Metrakos P
    Diaz Z
    Basik M
    Bertos N
    Park M
    Guettier C
    Adam R
    Hallett M
    Siegel PM
    Pokaż więcej
    Źródło:
    Oncogene [Oncogene] 2011 Mar 17; Vol. 30 (11), pp. 1318-28. Date of Electronic Publication: 2010 Nov 15.
    Typ publikacji:
    Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast Neoplasms/*genetics
    Breast Neoplasms/*pathology
    Cell Membrane/*metabolism
    Liver Neoplasms/*secondary
    Membrane Proteins/*physiology
    Breast Neoplasms/metabolism ; Cell Adhesion ; Cell Line, Tumor ; Cell Membrane/pathology ; Claudins ; Extracellular Matrix/metabolism ; Extracellular Matrix/pathology ; Female ; Fibronectins/metabolism ; Humans ; Immunohistochemistry ; Integrin alpha2beta1/metabolism ; Integrin alpha5beta1/metabolism ; Liver Neoplasms/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome.
    Autorzy:
    Przybytkowski E; Department of Oncology, Lady Davis Institute, Sir Mortimer B, Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
    Ferrario C
    Basik M
    Pokaż więcej
    Źródło:
    BMC medical genomics [BMC Med Genomics] 2011 Jan 27; Vol. 4, pp. 16. Date of Electronic Publication: 2011 Jan 27.
    Typ publikacji:
    Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Gene Fusion*
    Genome*
    Comparative Genomic Hybridization/*methods
    DNA Copy Number Variations/*genetics
    Algorithms ; Breast Neoplasms/genetics ; Cell Line, Tumor ; DNA/genetics ; DNA, Complementary/genetics ; Female ; Gene Dosage ; Humans ; Neoplasms/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.
    Autorzy:
    Aguilar-Mahecha A; Lady Davis Institute for Biomedical Research, Department of Oncology, Montréal, Québec, H3T 1E2, Canada.
    Cantin C; Biotechnology Research Institute, National Research Council of Canada, Montréal, Québec, H4P 2R2, Canada.
    O'Connor-McCourt M; Biotechnology Research Institute, National Research Council of Canada, Montréal, Québec, H4P 2R2, Canada.
    Nantel A; Biotechnology Research Institute, National Research Council of Canada, Montréal, Québec, H4P 2R2, Canada.
    Basik M; Lady Davis Institute for Biomedical Research, Department of Oncology, Montréal, Québec, H3T 1E2, Canada.
    Pokaż więcej
    Źródło:
    Proteome science [Proteome Sci] 2009 Apr 06; Vol. 7, pp. 15. Date of Electronic Publication: 2009 Apr 06.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.
    Autorzy:
    Voisin L; Institut de Recherche en Immunologie et Cancérologie, Montreal, Quebec, Canada.
    Julien C
    Duhamel S
    Gopalbhai K
    Claveau I
    Saba-El-Leil MK
    Rodrigue-Gervais IG
    Gaboury L
    Lamarre D
    Basik M
    Meloche S
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2008 Nov 17; Vol. 8, pp. 337. Date of Electronic Publication: 2008 Nov 17.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cell Transformation, Neoplastic*
    Adenocarcinoma/*secondary
    Intestinal Mucosa/*pathology
    Intestinal Neoplasms/*pathology
    MAP Kinase Kinase 1/*metabolism
    MAP Kinase Kinase 2/*metabolism
    Adenocarcinoma/enzymology ; Adenocarcinoma/pathology ; Animals ; Anoikis ; Cell Line, Tumor ; Colorectal Neoplasms/enzymology ; Colorectal Neoplasms/pathology ; Humans ; Intestinal Mucosa/metabolism ; Intestinal Neoplasms/enzymology ; MAP Kinase Kinase 1/genetics ; MAP Kinase Kinase 2/genetics ; Matrix Metalloproteinases/metabolism ; Mice ; Mice, Nude ; Neoplasm Invasiveness ; Neoplasm Transplantation ; Oligonucleotide Array Sequence Analysis ; Protein Isoforms/metabolism ; RNA Interference ; Rats
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
    Autorzy:
    Huusko P; Translational Genomics Research Institute, Cancer Drug Development Laboratory, 20 Firstfield Road, Suite 110, Gaithersburg, Maryland 20878, USA.
    Ponciano-Jackson D
    Wolf M
    Kiefer JA
    Azorsa DO
    Tuzmen S
    Weaver D
    Robbins C
    Moses T
    Allinen M
    Hautaniemi S
    Chen Y
    Elkahloun A
    Basik M
    Bova GS
    Bubendorf L
    Lugli A
    Sauter G
    Schleutker J
    Ozcelik H
    Elowe S
    Pawson T
    Trent JM
    Carpten JD
    Kallioniemi OP
    Mousses S
    Pokaż więcej
    Źródło:
    Nature genetics [Nat Genet] 2004 Sep; Vol. 36 (9), pp. 979-83. Date of Electronic Publication: 2004 Aug 08.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Mutation*
    Prostatic Neoplasms/*genetics
    Receptor, EphB2/*genetics
    Cell Line, Tumor ; Codon, Nonsense ; Emetine/pharmacology ; Genes, Tumor Suppressor ; Humans ; Male ; Molecular Sequence Data ; Oligonucleotide Array Sequence Analysis ; RNA Stability ; Transfection
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-18 z 18

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies